ArticleBMJ open2026

Prospective evaluation of real-world safety, symptoms improvement and adherence to mavacamten among Iranian patients with hypertrophic obstructive cardiomyopathy (PERSIA-HOCM): protocol of a multicentre observational study.

Amirhossein Ghaseminejad-Raeini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.